Subsidies
Subsidies
subsidy
Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
---|---|---|---|---|---|---|---|
Acquisition of spectrum analyzer for characterization of circuits in millimeter wavelengths. | 2020-CIEN-000099-01 | PROVINCIAL GOVERNMENT OF GIPUZKOA | University of Navarra | Program network guipuzcoana for Science, Technology and Innovation 2020 | 24-11-2020 | 27.965,00€ | - |
Personalized Planning in RadioTherapy Through Integrative Modeling of Local Dose Effect and New Dosimetric Constraints | AC20/00123 | HIGH SCHOOL CARLOS III HEALTH CENTRE | FIMA 2020 AES International Joint Programming Projects | 24-11-2020 | 18.150,00€ | - | |
Plasma extracellular vesicles (EVs): the key for precision medicine in Glioblastoma | AC20/00094 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES International Joint Programming | 24-11-2020 | 38.720,00€ | - |
Correlation between tau deposition, neuronal dysfunction and clinical phenotype in patients with Primary Progressive Paralysis: programs of study neuroimaging and Histology. | PI20/00245 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 95.590,00€ | ERDF funds |
Study of predictive markers of response and resistance to the combination of immunotherapy (anti-PD-L1) and PARP inhibitors in recurrent ovarian cancer. | PI20/00959 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2020 AES Projects research | 24-11-2020 | 220.220,00€ | ERDF funds |
programs of study functional, molecular and clinical role of laminin C2 (LAMC2) in pancreatic cancer | PI20/01718 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 85.910,00€ | ERDF funds |
Role of MMP-10 and tissue perfusion in the diagnosis and follow-up of nephropathy and cardiovascular pathology in patients with diabetes mellitus subject 2. | PI20/01678 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 102.608,00€ | ERDF funds |
Myopia vs. pathological myopia, two different processes? From exome to lifestyle. MYoriGENE Study | PI20/00251 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 92.565,00€ | ERDF funds |
Comprehensive empowerment to gain health: longitudinal analysis of the SUN cohort. | PI20/00564 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 79.860,00€ | ERDF funds |
Role of the inflammasome in the regulation of intestinal barrier disruption and metabolic inflammation in a context of obesity and diabetes subject 2. | PI20/00927 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 156.695,00€ | ERDF funds |
Analysis of basophil gene expression and serum proteome in patients with chronic urticaria and/or histaminergic angioedema. | PI20/01536 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 135.520,00€ | ERDF funds |
Translation, cultural adaptation and validation of the Person-Centred Practice Inventory-Staff scale (PCPI-S) and the Person-Centred Practice Inventory-Student scale (PCPI-ST). Centred practice inventory-student scale (PCPI-ST) | PI20/01644 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 58.080,00€ | ERDF funds |
Markers of hypoxia at the confluence of COPD, SAHS and lung cancer (project ECCO) | PI20/01689 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2020 AES Projects research | 24-11-2020 | 87.604,00€ | ERDF funds |
Blocking the Unfolded Protein Response: a novel strategy to increase the efficacy of immune check-point inhibitors in hepatocellular carcinoma. | PI20/01663 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2020 AES Projects research | 24-11-2020 | 159.720,00€ | ERDF funds |
Role of GDF15 in age-related metabolic alterations in the context of obesity. | PI20/00080 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 145.200,00€ | ERDF funds |
essay multicenter, open-label, controlled, randomized clinical trial to evaluate the efficacy of the OIT control application in the monitoring of patients on ITO with food. | PI20/00219 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 87.120,00€ | ERDF funds |
Role of transcriptional regulatory mechanisms in the pathogenesis and treatment of MDS. | PI20/01308 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 275.880,00€ | ERDF funds |
Identification of biomarkers for the detection of radionecrosis in patients treated with stereotactic radiotherapy and development experimental of new therapies for its prevention. | PI20/01531 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 123.420,00€ | ERDF funds |
Prospective registry of hypofractionation with photon therapy and proton therapy with GaPSMA-positive area overprinting in salvage after prostatectomy. | pi20/01598 | HIGH SCHOOL CARLOS III HEALTH CENTRE | University of Navarra | 2020 AES Projects research | 24-11-2020 | 68.970,00€ | ERDF funds |
Intratumoral administration of immunotherapeutic agents and radiotherapy to potentiate systemic and local antitumor effects | PI20/00434 | HIGH SCHOOL CARLOS III HEALTH CENTRE | high school of research Sanitaria de Navarra - IdiSNA | 2020 AES Projects research | 24-11-2020 | 111.320,00€ | ERDF funds |